UBC Medical Indonesia Tbk. vs Logindo Samudramakmur Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp148 (market cap 576.7B, 3.48M 24h volume), while Logindo Samudramakmur Tbk. trades at Rp101 (market cap 574.16B, 12.07M 24h volume). The key difference: UBC Medical Indonesia Tbk. and Logindo Samudramakmur Tbk. are close in size by market cap, and Logindo Samudramakmur Tbk. is more actively traded (12.07M versus 3.48M). Which is the better fit depends on your goals.
| LABS | LEAD | |
|---|---|---|
Market Cap | 576.7B | 574.16B |
Volume | 3.48M | 12.07M |
Lot | 34.82K | 120.69K |
Turnover | 522.79M | 1.2B |
Average Price | 150.13 | 99.77 |
Value | 522.79M | 1.2B |
Indicative Equilibrium Price | 148 | 101 |
Indicative Equilibrium Volume | 350 | 3.23K |
Trailing returns across standard periods
Latest headlines on both assets
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →PT Logindo Samudramakmur Tbk (the Company) is domiciled and was established in Jakarta, Indonesia based on Notarial Deed No. 55 of Nurul Hidajati Handoko, SH., Public Notary in Jakarta dated August 23, 1995. The company currently owns and operates a fleet of 58 offshore support with various types and functions. The company has a portfolio of customers ranging from mining oil and gas local to multinational.
Read more on LEAD →